We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Weibo
WB
$1.95B
| $1.86M | ﹤0.01% |
108,898
+10,100
| +10% | +$195K |
|
|
ROCC
2402
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.86M | ﹤0.01% |
59,009
-16,058
| -21% | -$565K |
|
|
THR
2403
DELISTED
Thermon Group Holdings
THR
| $1.85M | ﹤0.01% |
120,325
-2,968
| -2% | -$48.8K |
|
2404
CEVA Inc
CEVA
$1.08B
| $1.85M | ﹤0.01% |
70,549
+102
| +0.1% | +$3.27K |
|
2405
UBS Group
UBS
$176B
| $1.85M | ﹤0.01% |
127,438
| – | – |
|
|
GOOD
2406
Gladstone Commercial Corp
GOOD
$627M
| $1.85M | ﹤0.01% |
119,166
-2,342
| -2% | -$44.6K |
|
|
BHIL
2407
DELISTED
Benson Hill, Inc.
BHIL
| $1.84M | ﹤0.01% |
19,240
+3,258
| +20% | +$359K |
|
|
AFCG
2408
AFC Gamma
AFCG
$63.4M
| $1.84M | ﹤0.01% |
176,118
+47,661
| +37% | +$550K |
|
2409
EVgo
EVGO
$229M
| $1.84M | ﹤0.01% |
232,780
-4,381
| -2% | -$38.2K |
|
2410
Bristow Group
VTOL
$1.36B
| $1.84M | ﹤0.01% |
78,420
-5,004
| -6% | -$130K |
|
2411
Design Therapeutics
DSGN
$876M
| $1.84M | ﹤0.01% |
110,134
-1,327
| -1% | -$26.4K |
|
2412
QuinStreet
QNST
$1.21B
| $1.83M | ﹤0.01% |
174,791
-9,015
| -5% | -$103K |
|
|
CFB
2413
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.82M | ﹤0.01% |
139,736
-10,998
| -7% | -$149K |
|
2414
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $1.82M | ﹤0.01% |
50,000
-25,000
| -33% | -$1.02M |
|
2415
Xenon Pharmaceuticals
XENE
$6.12B
| $1.82M | ﹤0.01% |
50,360
+6,049
| +14% | +$217K |
|
|
AMRS
2416
DELISTED
Amyris Inc.
AMRS
| $1.81M | ﹤0.01% |
621,127
+458,502
| +282% | +$1.25M |
|
2417
OrthoPediatrics
KIDS
$595M
| $1.81M | ﹤0.01% |
39,229
-448
| -1% | -$22K |
|
|
INFA
2418
DELISTED
Informatica
INFA
| $1.81M | ﹤0.01% |
90,123
-11,824
| -12% | -$255K |
|
|
FPI
2419
Farmland Partners
FPI
$432M
| $1.8M | ﹤0.01% |
142,448
-2,831
| -2% | -$40.3K |
|
|
ALBO
2420
DELISTED
Albireo Pharma Inc
ALBO
| $1.8M | ﹤0.01% |
93,063
+55,774
| +150% | +$1.15M |
|
|
CATC
2421
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.8M | ﹤0.01% |
22,581
-548
| -2% | -$45.1K |
|
2422
Paysafe
PSFE
$375M
| $1.8M | ﹤0.01% |
108,700
-2,083
| -2% | -$46.6K |
|
|
DICE
2423
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.79M | ﹤0.01% |
88,499
-1,604
| -2% | -$29.2K |
|
2424
Xponential Fitness
XPOF
$211M
| $1.79M | ﹤0.01% |
98,128
+23,909
| +32% | +$403K |
|
|
FLIC
2425
DELISTED
First of Long Island Corp
FLIC
| $1.79M | ﹤0.01% |
103,705
-1,156
| -1% | -$21.3K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.